http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2862067-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5941305510c5714dfa0a0d94047e1e04 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_950564294759c72e13437ee92f05334d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c243a1f3f4994ae92b82a9390c75d206 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9786b757acd1cdfd216c9b64a9c3719 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38567c4f352f682554f7579de8ae20d9 |
| publicationDate | 2014-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2862067-A1 |
| titleOfInvention | Pharmaceutical composition of recombinant polyclonal immunoglobulins |
| abstract | There is disclosed a recombinant pharmaceutical composition comprising a large plurality of recombinant immunoglobulins made by expression of a wide diversity of antibodies from a recombinant antibody library, preferably obtained from a wide diversity of human sources, synthetic or semi- synthetic germline immunoglobulin sequences, or a combination thereof, and then purified. Mammalian cell expression antibody libraries normally produce antibodies with significant diversity or different antibodies that bind to different targets. There is further disclosed a recombinant pharmaceutical composition made from a mammalian expression library configured to excrete, rather than display their antibodies on the cell surface, and then purified to form the pharmaceutical composition from the excreted antibodies. |
| priorityDate | 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 152.